Cognition Therapeutics Ownership | Who Owns Cognition Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Cognition Therapeutics Ownership Summary

Cognition Therapeutics is owned by 33.44% institutional investors, 0.71% insiders, and 65.85% retail investors. Bios capital management, lp is the largest institutional shareholder, holding 9.42% of CGTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.52% of its assets in Cognition Therapeutics shares.

CGTX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Cognition Therapeutics	33.44%	0.71%	65.85%
Sector	Healthcare Stocks	42.53%	10.81%	46.67%
Industry	Biotech Stocks	45.24%	10.75%	44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bios capital management, lp	6.00M	9.42%	$8.10M
Davenport	2.69M	4.22%	$3.63M
Vanguard group	2.68M	4.21%	$3.62M
Tang capital management	1.20M	1.88%	$1.62M
Chescapmanager	997.03K	1.57%	$1.35M
Blackrock funding, inc. /de	968.70K	1.52%	$1.31M
Jane street group	926.15K	1.45%	$1.25B
Renaissance	713.50K	1.12%	$963.23K
Geode capital management	712.73K	1.12%	$962.53K
Hilton capital management	581.15K	0.91%	$784.55K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bios capital management, lp	6.00M	9.11%	$8.10M
Chescapmanager	997.03K	0.13%	$1.35M
American financial group	205.00K	0.11%	$276.75K
Hilton capital management	581.15K	0.06%	$784.55K
Tang capital management	1.20M	0.06%	$1.62M
Gsa capital partners llp	196.36K	0.02%	$265.00K
Castle wealth management	44.01K	0.02%	$59.41K
Fca corp /tx	52.54K	0.02%	$70.92K
Davenport	2.69M	0.02%	$3.63M
Voss capital	450.00K	0.01%	$139.41K

Top Buyers

Holder	Shares	% Assets	Change
Davenport	2.69M	0.02%	2.69M
Vanguard group	2.68M	0.00%	1.38M
Tang capital management	1.20M	0.06%	1.20M
Jane street group	926.15K	0.00%	912.94K
Blackrock funding, inc. /de	968.70K	-	891.84K

Top Sellers

Holder	Shares	% Assets	Change
Acadian asset management	-	-	-701.94K
Awm investment company	-	-	-650.00K
Timelo investment management	-	-	-361.40K
Aigh capital management	-	-	-300.77K
Cm management	-	-	-250.00K

New Positions

Holder	Shares	% Assets	Change	Value
Davenport	2.69M	0.02%	2.69M	$3.63M
Tang capital management	1.20M	0.06%	1.20M	$1.62M
Hilton capital management	581.15K	0.06%	581.15K	$784.55K
Quadrature capital	263.09K	0.00%	263.09K	$357.80K
Graham capital management	226.56K	0.00%	226.56K	$305.85K

Sold Out

Holder	Change
Jpmorgan chase	-69.00
Opal wealth advisors	-500.00
Coldstream capital management	-1.24K
Sandy spring bank	-2.00K
Qube research	-2.12K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	64	33.33%	21,298,058	89.46%	33	10.73%	49	172.22%	4	-42.86%
Jun 30, 2025	48	-	11,241,507	-3.32%	17	4.99%	18	-10.00%	7	-36.36%
Mar 31, 2025	1	-97.78%	6,000,000	-45.80%	9	1.29%	-	-100.00%	-	-100.00%
Dec 31, 2024	30	-23.08%	10,129,593	138.12%	25	22.62%	13	-18.75%	6	50.00%
Sep 30, 2024	38	-17.39%	4,196,749	-20.97%	10	4.19%	15	-21.05%	4	-42.86%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	988.30K	1.52%	-21.60K
Vanguard Institutional Extnd Mkt Idx Tr	527.22K	0.81%	245.41K
Fidelity Extended Market Index	273.31K	0.31%	78.37K
BlackRock Extended Equity Market K	64.70K	0.16%	-27.00
Fidelity Total Market Index	102.74K	0.12%	43.64K
Fidelity Series Total Market Index	97.43K	0.11%	49.23K
iShares Micro-Cap ETF	64.20K	0.10%	-
Extended Equity Market Fund K	62.76K	0.10%	-1.25K
Spartan Extended Market Index Pool F	80.77K	0.09%	51.38K
Bridgeway Ultra-Small Company Market	31.87K	0.08%	-44.83K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jan 31, 2025	Ricciardi Lisa	CEO & President	Buy	$30.00K
Mar 14, 2024	Ricciardi Lisa	CEO & President	Buy	$9.97K
Nov 29, 2022	RICHSTONE ELLEN B	-	Buy	$26.55K
Nov 28, 2022	Fletcher Aaron G.L.	-	Buy	$4.96K
Nov 28, 2022	Fletcher Aaron G.L.	-	Buy	$5.23K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	1	-
2024 Q2	-	-
2024 Q1	1	-

CGTX Ownership FAQ

Who Owns Cognition Therapeutics?

Cognition Therapeutics shareholders are primarily institutional investors at 33.44%, followed by 0.71% insiders and 65.85% retail investors. The average institutional ownership in Cognition Therapeutics's industry, Biotech Stocks , is 45.24%, which Cognition Therapeutics falls below.

Who owns the most shares of Cognition Therapeutics?

Cognition Therapeutics’s largest shareholders are Bios capital management, lp (6M shares, 9.42%), Davenport (2.69M shares, 4.22%), and Vanguard group (2.68M shares, 4.21%). Together, they hold 17.85% of Cognition Therapeutics’s total shares outstanding.

Does Blackrock own Cognition Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Cognition Therapeutics.

Who is Cognition Therapeutics’s biggest shareholder by percentage of total assets invested?

Bios capital management, lp is Cognition Therapeutics’s biggest shareholder by percentage of total assets invested, with 9.11% of its assets in 6M Cognition Therapeutics shares, valued at 8.1M$.

Who is the top mutual fund holder of Cognition Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cognition Therapeutics shares, with 1.52% of its total shares outstanding invested in 988.3K Cognition Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools